Literature DB >> 22622824

QT wave dispersion in patients with panic disorder.

Murad Atmaca1, Mustafa Yavuzkir, Filiz İzci, M Gurkan Gurok, Sahin Adiyaman.   

Abstract

OBJECTIVE: QT dispersion (QTd), defined as the maximal inter-lead difference in QT intervals on 12 leads of the surface electrocardiogram (ECG), reflects the regional heterogeneity of ventricular repolarization and has been suggested as an important marker for risk of arrhythmia in addition to the QT interval. Some investigators proposed that it might be a predisposing factor for arrhythmic events and sudden death. Thus, we aimed to investigate whether QTd differs in patients with panic disorder from that in healthy controls.
METHODS: In 40 panic disorder patients and 40 healthy controls, Q(max), Q(min), and QTd values were measured. In addition, the Hamilton depression rating scale and the panic agoraphobia scale were scored for both patients and healthy volunteers.
RESULTS: Q(max) and Q(min) values in the panic disorder patients were significantly higher than those in healthy controls. The mean corrected QTd was significantly greater in the patients than in the controls. One-way analysis of covariance (ANCOVA; using left atrial size, age and heart rate as covariates) also corrected the significant difference. In addition, ANCOVA revealed a significant main effect for the diagnosis, indicating a significantly higher QTd for patients compared with controls.
CONCLUSION: QTd might be associated with panic disorder. Future studies in larger samples evaluating the effects of treatment are required.

Entities:  

Mesh:

Year:  2012        PMID: 22622824      PMCID: PMC5560325          DOI: 10.1007/s12264-012-1237-3

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  24 in total

1.  Evaluation of autonomic influences on QT dispersion using the head-up tilt test in healthy subjects.

Authors:  M Nakagawa; N Takahashi; T Iwao; H Yonemochi; T Ooie; M Hara; T Saikawa; M Ito
Journal:  Pacing Clin Electrophysiol       Date:  1999-08       Impact factor: 1.976

Review 2.  Is panic disorder associated with coronary artery disease? A critical review of the literature.

Authors:  R Fleet; K Lavoie; B D Beitman
Journal:  J Psychosom Res       Date:  2000 Apr-May       Impact factor: 3.006

3.  The assessment of anxiety states by rating.

Authors:  M HAMILTON
Journal:  Br J Med Psychol       Date:  1959

4.  The influence of the call with a mobile phone on heart rate variability parameters in healthy volunteers.

Authors:  Ryszard Andrzejak; Rafal Poreba; Malgorzata Poreba; Arkadiusz Derkacz; Robert Skalik; Pawel Gac; Boguslaw Beck; Aleksandra Steinmetz-Beck; Witold Pilecki
Journal:  Ind Health       Date:  2008-08       Impact factor: 2.179

5.  Autonomic modulation and QT interval dispersion in hypertensive subjects with anxiety.

Authors:  G Piccirillo; E Viola; M Nocco; E Santagada; M Durante; C Bucca; V Marigliano
Journal:  Hypertension       Date:  1999-08       Impact factor: 10.190

6.  Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.

Authors: 
Journal:  Eur Heart J       Date:  1996-03       Impact factor: 29.983

7.  ACC/AHA guidelines for the clinical application of echocardiography: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Clinical Application of Echocardiography). Developed in collaboration with the American Society of Echocardiography.

Authors:  M D Cheitlin; J S Alpert; W F Armstrong; G P Aurigemma; G A Beller; F Z Bierman; T W Davidson; J L Davis; P S Douglas; L D Gillam; R P Lewis; A S Pearlman; J T Philbrick; P M Shah; R G Williams; J L Ritchie; K A Eagle; T J Gardner; A Garson; R J Gibbons; R A O'Rourke; T J Ryan
Journal:  J Am Coll Cardiol       Date:  1997-03-15       Impact factor: 24.094

8.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

9.  QT dispersion and sudden unexpected death in chronic heart failure.

Authors:  C S Barr; A Naas; M Freeman; C C Lang; A D Struthers
Journal:  Lancet       Date:  1994-02-05       Impact factor: 79.321

10.  Heart rate variability in coronary artery disease patients with and without panic disorder.

Authors:  Kim L Lavoie; Richard P Fleet; Catherine Laurin; Andre Arsenault; Sydney B Miller; Simon L Bacon
Journal:  Psychiatry Res       Date:  2004-10-30       Impact factor: 3.222

View more
  6 in total

1.  QT interval dispersion in the patients with central serous chorioretinopathy.

Authors:  Necati Dagli; Burak Turgut; Rumeysa Tanyildizi; Sabiha Kobat; Mehmet Ali Kobat; Orhan Dogdu
Journal:  Int J Ophthalmol       Date:  2015-02-18       Impact factor: 1.779

2.  P-wave and QT dispersion in patients with conversion disorder.

Authors:  Filiz Izci; Hilal Hocagil; Servet Izci; Vedat Izci; Merve Iris Koc; Rezzan Deniz Acar
Journal:  Ther Clin Risk Manag       Date:  2015-03-26       Impact factor: 2.423

Review 3.  Is panic disorder a disorder of physical fitness? A heuristic proposal.

Authors:  Giampaolo Perna; Daniela Caldirola
Journal:  F1000Res       Date:  2018-03-08

4.  Evaluation of TP-E Interval and TP-E/QT Ratio in Panic Disorder.

Authors:  Abdulmecit Afsin; Ramazan Asoğlu; Mehmet Hamdi Orum; Elvan Cicekci
Journal:  Medicina (Kaunas)       Date:  2020-04-28       Impact factor: 2.430

5.  QT and P-wave dispersion during the manic phase of bipolar disorder.

Authors:  Mehmet Gurkan Gurok; Hasan Korkmaz; Sevler Yıldız; Dilek Bakış; Murad Atmaca
Journal:  Neuropsychiatr Dis Treat       Date:  2019-07-03       Impact factor: 2.570

6.  Transmural dispersion of repolarization and atrial electromechanical coupling: complementary indices for quantifying cardiac electrical heterogeneity in patients with conversion disorder.

Authors:  Alptug Tokatli; Omer Yiginer; Gokhan Degirmencioglu; Fethi Kilicaslan; Mehmet Uzun
Journal:  Ther Clin Risk Manag       Date:  2015-07-20       Impact factor: 2.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.